Telemus Capital, LLC Merck & Co., Inc. Transaction History

Telemus Capital, LLC

$1.2 Billion
Q4 2023

A detailed history of Telemus Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Telemus Capital, LLC holds 26,876 shares of MRK stock, worth $2.77 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

26,876

Previous 28,015 4.07%

Holding current value

$2.77 Million

Previous $2.88 Million 1.6%

% of portfolio

0.25%

Previous 0.27%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$100.18 - $109.02 $114,105 - $124,173	-1,139 Reduced 4.07%	26,876 $2.93 Million
Q3 2023 Oct 25, 2023	SELL	$102.95 - $114.33 $190,560 - $211,624	-1,851 Reduced 6.2%	28,015 $2.88 Million
Q2 2023 Jul 10, 2023	BUY	$108.61 - $118.38 $14,662 - $15,981	135 Added 0.45%	29,866 $3.45 Million
Q1 2023 Apr 11, 2023	BUY	$102.94 - $114.86 $82,454 - $92,002	801 Added 2.77%	29,731 $3.16 Million
Q4 2022 Jan 11, 2023	BUY	$87.44 - $112.11 $1.01 Million - $1.29 Million	11,547 Added 66.43%	28,930 $0
Q3 2022 Oct 11, 2022	BUY	$84.53 - $94.96 $22,823 - $25,639	270 Added 1.58%	17,383 $1.5 Million
Q2 2022 Aug 10, 2022	SELL	$83.49 - $94.64 $134,836 - $152,843	-1,615 Reduced 8.62%	17,113 $1.56 Million
Q1 2022 Apr 06, 2022	SELL	$73.51 - $82.4 $19,186 - $21,506	-261 Reduced 1.37%	18,728 $1.54 Million
Q4 2021 Feb 01, 2022	SELL	$72.28 - $90.54 $46,042 - $57,673	-637 Reduced 3.25%	18,989 $1.46 Million
Q3 2021 Oct 27, 2021	BUY	$71.68 - $78.83 $181,780 - $199,912	2,536 Added 14.84%	19,626 $1.47 Million
Q2 2021 Aug 09, 2021	SELL	$70.31 - $77.77 $1.67 Million - $1.85 Million	-23,812 Reduced 58.22%	17,090 $1.33 Million
Q1 2021 Apr 20, 2021	BUY	$68.86 - $81.11 $11,637 - $13,707	169 Added 0.41%	40,902 $3.15 Million
Q4 2020 Jan 28, 2021	BUY	$71.77 - $79.65 $15,574 - $17,284	217 Added 0.54%	40,733 $3.33 Million
Q3 2020 Nov 02, 2020	BUY	$73.18 - $82.95 $4,756 - $5,391	65 Added 0.16%	40,516 $3.23 Million
Q2 2020 Jul 17, 2020	SELL	$70.42 - $80.13 $23,661 - $26,923	-336 Reduced 0.82%	40,451 $3.1 Million
Q1 2020 Jun 05, 2020	SELL	$63.36 - $87.82 $362,926 - $503,032	-5,728 Reduced 12.31%	40,787 $3.29 Million
Q4 2019 Jan 24, 2020	BUY	$77.58 - $87.54 $24,748 - $27,925	319 Added 0.69%	46,515 $4.23 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $23,280 - $25,376	306 Added 0.67%	46,196 $3.89 Million
Q2 2019 Aug 09, 2019	SELL	$69.84 - $81.59 $249,119 - $291,031	-3,567 Reduced 7.21%	45,890 $3.81 Million
Q1 2019 May 02, 2019	SELL	$69.58 - $79.36 $1.54 Million - $1.76 Million	-22,148 Reduced 30.93%	49,457 $4.11 Million
Q4 2018 Feb 06, 2019	BUY	$65.24 - $75.71 $1.45 Million - $1.68 Million	22,191 Added 44.91%	71,605 $5.47 Million
Q3 2018 Oct 23, 2018	BUY	$57.69 - $67.84 $128,821 - $151,486	2,233 Added 4.73%	49,414 $3.51 Million
Q2 2018 Jul 31, 2018	SELL	$50.83 - $59.72 $15,960 - $18,752	-314 Reduced 0.66%	47,181 $2.86 Million
Q1 2018 Apr 27, 2018	SELL	$50.96 - $59.23 $38,321 - $44,540	-752 Reduced 1.56%	47,495 $2.59 Million
Q4 2017 Feb 02, 2018	BUY	$51.62 - $61.64 $918,990 - $1.1 Million	17,803 Added 58.48%	48,247 $2.72 Million
Q3 2017 Nov 03, 2017	BUY	$58.67 - $63.13 $151,603 - $163,127	2,584 Added 9.27%	30,444 $1.95 Million
Q2 2017 Apr 03, 2018	BUY	N/A	734 Added 2.71%	27,860 $1.79 Million
Q1 2017 Apr 03, 2018	BUY	N/A	27,126	27,126 $1.72 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.

Account

Telemus Capital, LLC Merck & Co., Inc. Transaction History